Systems analysis of immunity to pneumococcal vaccination in preterm and full term infants

Clicks: 16
ID: 329099
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #436 of 503 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 503 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Preterm infants mount lower humoral responses to the 13-valent pneumococcal conjugate vaccine (PCV13) than full-term infants; however, the long-term impact of prematurity on vaccine-induced protection remains unclear. This study investigates the innate and adaptive immune responses to a 3+1 PCV13 schedule in preterm versus full-term infants using transcriptomic profiling and B-cell immunophenotyping. Methods Thirty-eight infants (19 preterm,19 full-term) received PCV13 at 2,4,6, and 12 months. Polysaccharide (PS)1- and PS9V-specific memory B cells (MBCs) were enumerated and phenotyped by flow cytometry, while PS-specific IgG concentrations were measured by ELISA before and after the third and booster doses. RNA sequencing was performed before and 3 days after the third dose. Results Primary PCV13 immunization induced a markedly broader transcriptional response in preterm than in full-term infants (267 differentially expressed genes vs. 29 in full-term), dominated by pro-inflammatory signatures. Preterm infants exhibited higher frequencies of total and PS-specific extra-germinal center(GC) MBCs but lower switched MBCs following primary immunization; these differences largely converged post-booster. PS-specific IgG titers remained lower in preterm infants both after primary and booster doses. PS-specific switched MBCs post-primary were positively correlated with antibody titers post-booster. The broad upregulation of pro-inflammatory genes in preterm infants was negatively correlated with their PS-specific antibody titers. Conclusions PCV13 immunization elicits distinct immunological profiles in preterm vs full-term infants, marked by skewed B-cell differentiation and broader pro-inflammatory transcriptional activity. Booster immunization largely harmonized MBC composition across gestational groups, while early GC-derived MBC populations emerged as candidate correlated of durable vaccine-induced immunity.
Reference Key
openalex_W7213553729 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Maria Geropeppa, Ioanna Papadatou, Kleio‐Maria Verrou, Peter Lembessis, Pantelis Hatzis, Marianna Tzanoudaki, Lefkothea Dova, Aikaterini Drougia, Eleni Maragoudaki, Aikaterini Skoufou, Eleni-Maria Tetorou, Eirini Loukatou, Vasileios Giapros, Christina Kanaka‐Gantenbein, Tania Siahanidou, Vana Spoulou
Are you one of these authors? Claim your profile
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag473
URL
https://doi.org/10.1093/infdis/jiag473
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.